N⁶-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6. doi:10.1038/s41572-020-00240-3
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380:1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 2018;379:54–63. doi:10.1056/NEJMoa1717002
   PubMed Web of Science ®Google Scholar
• Ajoolabady A, Tang D, Kroemer G, Ren J. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy. Br J Cancer. 2023;128:190–205. doi:10.1038/s41416-022-01998-x
   PubMed Web of Science ®Google Scholar
• Baretti M, Kim AK, Anders RA. Expanding the immunotherapy roadmap for hepatocellular carcinoma. Cancer Cell. 2022;40:252–254. doi:10.1016/j.ccell.2022.02.017
   PubMed Web of Science ®Google Scholar
• Zheng X, Hou Z, Qian Y, et al. Tumors evade immune cytotoxicity by altering the surface topology of NK cells. Nat Immunol. 2023;24:802–813. doi:10.1038/s41590-023-01462-9
   PubMed Web of Science ®Google Scholar
• Liu T, Wang Z, Ye L, et al. Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growth. Nat Cell Biol. 2023;25:273–284. doi:10.1038/s41556-022-01061-0
   PubMed Web of Science ®Google Scholar
• Yuan JH, Liu XN, Wang TT, et al. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1. Nat Cell Biol. 2017;19:820–832. doi:10.1038/ncb3538
   PubMed Web of Science ®Google Scholar
• Schulze K, Imbeaud S, Letouze E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47:505–511. doi:10.1038/ng.3252
   PubMed Web of Science ®Google Scholar
• Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers. Mol Biol Cell. 2002;13:1929–1939. doi:10.1091/mbc.02-02-0023
   PubMed Web of Science ®Google Scholar
• Andrisani O. Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma. Hepatoma Res. 2021;7. doi:10.20517/2394-5079.2020.83
   PubMedGoogle Scholar
• Sengupta I, Mondal P, Sengupta A, et al. Epigenetic regulation of Fructose-1,6-bisphosphatase 1 by host transcription factor Speckled 110 kDa during hepatitis B virus infection. FEBS J. 2022;289:6694–6713. doi:10.1111/febs.16544
   PubMed Web of Science ®Google Scholar
• Meunier L, Hirsch TZ, Caruso S, et al. DNA methylation signatures reveal the diversity of processes remodeling hepatocellular carcinoma methylomes. Hepatology. 2021;74:816–834. doi:10.1002/hep.31796
   PubMed Web of Science ®Google Scholar
• Zhu XT, Yuan JH, Zhu TT, Li YY, Cheng XY. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3. FEBS J. 2016;283:3739–3754. doi:10.1111/febs.13839
   PubMed Web of Science ®Google Scholar
• Zhao W, Mo H, Liu R, Chen T, Yang N, Liu Z. Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression. Br J Cancer. 2022;127:202–210. doi:10.1038/s41416-022-01784-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Zeng J, Chen W, Fan J, Hylemon PB, Zhou H. Long Noncoding RNA H19: a novel oncogene in liver cancer. Noncoding RNA. 2023;9. doi:10.3390/ncrna9020019
   Web of Science ®Google Scholar
• Peng W, Bai S, Zheng M, et al. An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma. Transl Oncol. 2023;31:101651. doi:10.1016/j.tranon.2023.101651
   PubMed Web of Science ®Google Scholar
• Zhang X, Jiang Q, Li J, et al. KCNQ1OT1 promotes genome-wide transposon repression by guiding RNA-DNA triplexes and HP1 binding. Nat Cell Biol. 2022;24:1617–1629. doi:10.1038/s41556-022-01008-5
   PubMed Web of Science ®Google Scholar
• Unfried JP, Ulitsky I. Substoichiometric action of long noncoding RNAs. Nat Cell Biol. 2022;24:608–615. doi:10.1038/s41556-022-00911-1
   PubMed Web of Science ®Google Scholar
• Beucher A, Miguel-Escalada I, Balboa D, et al. The HASTER lncRNA promoter is a cis-acting transcriptional stabilizer of HNF1A. Nat Cell Biol. 2022;24:1528–1540. doi:10.1038/s41556-022-00996-8
   PubMed Web of Science ®Google Scholar
• Li G, Kryczek I, Nam J, et al. LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nat Cell Biol. 2021;23:526–537. doi:10.1038/s41556-021-00672-3
   PubMed Web of Science ®Google Scholar
• Li Y, Ding T, Hu H, et al. LncRNA-ATB participates in the regulation of calcium oxalate crystal-induced renal injury by sponging the miR-200 family. Mol Med. 2021;27:143. doi:10.1186/s10020-021-00403-2
   PubMed Web of Science ®Google Scholar
• Xia A, Yuan W, Wang Q, et al. The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription. Nat Cancer. 2022;3:203–218. doi:10.1038/s43018-021-00315-4
   PubMedGoogle Scholar
• Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25:666–681. doi:10.1016/j.ccr.2014.03.010
   PubMed Web of Science ®Google Scholar
• Li S, Hu X, Yu S, et al. Hepatic stellate cell-released CXCL1 aggravates HCC malignant behaviors through the MIR4435-2HG/miR-506-3p/TGFB1 axis. Cancer Sci. 2023;114:504–520. doi:10.1111/cas.15605
   PubMed Web of Science ®Google Scholar
• Zhu N, Chen X, Zhao J, et al. Hypoxia-induced LINC00674 facilitates hepatocellular carcinoma progression by activating the NOX1/mTOR signaling pathway. J Cancer. 2022;13:3177–3188. doi:10.7150/jca.76458
   PubMed Web of Science ®Google Scholar
• Li JK, Chen C, Liu JY, et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer. 2017;16:111. doi:10.1186/s12943-017-0681-0
   PubMed Web of Science ®Google Scholar
• Ito-Kureha T, Leoni C, Borland K, et al. The function of Wtap in N(6)-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells. Nat Immunol. 2022;23:1208–1221. doi:10.1038/s41590-022-01268-1
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu X, Qi M, et al. N(6)-methyladenosine regulates maternal RNA maintenance in oocytes and timely RNA decay during mouse maternal-to-zygotic transition. Nat Cell Biol. 2022;24:917–927. doi:10.1038/s41556-022-00915-x
   PubMed Web of Science ®Google Scholar
• Xu Y, Lv D, Yan C, et al. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification. Cancer Cell Int. 2022;22:11. doi:10.1186/s12935-021-02433-6
   PubMed Web of Science ®Google Scholar
• Dong L, Chen C, Zhang Y, et al. The loss of RNA N(6)-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8(+) T cell dysfunction and tumor growth. Cancer Cell. 2021;39:945–957 e10. doi:10.1016/j.ccell.2021.04.016
   PubMed Web of Science ®Google Scholar
• Weng H, Huang F, Yu Z, et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40:1566–1582. doi:10.1016/j.ccell.2022.10.004
   PubMed Web of Science ®Google Scholar
• Cheng Y, Xie W, Pickering BF, et al. N(6)-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation. Cancer Cell. 2021;39:958–972 e8. doi:10.1016/j.ccell.2021.04.017
   PubMed Web of Science ®Google Scholar
• Cai Z, Zhang Y, Yang L, et al. ALKBH5 in mouse testicular Sertoli cells regulates Cdh2 mRNA translation to maintain blood-testis barrier integrity. Cell Mol Biol Lett. 2022;27:101. doi:10.1186/s11658-022-00404-x
   PubMed Web of Science ®Google Scholar
• Zhang R, Qu Y, Ji Z, et al. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner. Cell Mol Biol Lett. 2022;27:55. doi:10.1186/s11658-022-00349-1
   PubMed Web of Science ®Google Scholar
• Zhang X, Lu N, Wang L, et al. Recent advances of m(6)A methylation modification in esophageal squamous cell carcinoma. Cancer Cell Int. 2021;21:421. doi:10.1186/s12935-021-02132-2
   PubMed Web of Science ®Google Scholar
• Sun W, Li Y, Ma D, et al. ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1. Cell Mol Biol Lett. 2022;27:26. doi:10.1186/s11658-022-00329-5
   PubMed Web of Science ®Google Scholar
• Du H, Zou NY, Zuo HL, Zhang XY, Zhu SC. YTHDF3 mediates HNF1alpha regulation of cervical cancer radio-resistance by promoting RAD51D translation in an m6A-dependent manner. FEBS J. 2022;290:1920–1935. doi:10.1111/febs.16681
   PubMed Web of Science ®Google Scholar
• Shimura T, Kandimalla R, Okugawa Y, et al. Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer. Br J Cancer. 2022;126:228–237. doi:10.1038/s41416-021-01581-w
   PubMed Web of Science ®Google Scholar
• Dai YZ, Liu YD, Li J, et al. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6) A-dependent manner. Cell Mol Biol Lett. 2022;27:41. doi:10.1186/s11658-022-00342-8
   PubMed Web of Science ®Google Scholar
• Lan J, Xu B, Shi X, Pan Q, Tao Q. WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett. 2022;27:51. doi:10.1186/s11658-022-00350-8
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang J, Jin Y, et al. YTHDF2-mediated FGF14-AS2 decay promotes osteolytic metastasis of breast cancer by enhancing RUNX2 mRNA translation. Br J Cancer. 2022;127:2141–2153. doi:10.1038/s41416-022-02006-y
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Xiao Y, Wang Y, Tang Q, Wei L, Zhang X, Jia G. An elongation- and ligation-based qPCR amplification method for the radiolabeling-free detection of locus-specific N(6) -methyladenosine modification. Angew Chem Int Ed Engl. 2018;57:15995–16000. doi:10.1002/anie.201807942
   PubMed Web of Science ®Google Scholar
• Liu XN, Yuan JH, Wang TT, Pan W, Sun SH. An alternative POLDIP3 transcript promotes hepatocellular carcinoma progression. Bio Pharmacother. 2017;89:276–283. doi:10.1016/j.biopha.2017.01.139
   PubMed Web of Science ®Google Scholar
• Wei H, Xu Z, Chen L, et al. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1alpha/VEGF signaling. Cell Death Dis. 2022;13:102. doi:10.1038/s41419-022-04505-5
   PubMed Web of Science ®Google Scholar
• Pu J, Li W, Wang A, et al. Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages. Cell Death Dis. 2021;12:1103. doi:10.1038/s41419-021-04309-z
   PubMed Web of Science ®Google Scholar
• Pu J, Zhang Y, Wang A, et al. ADORA2A-AS1 restricts hepatocellular carcinoma progression via binding hur and repressing FSCN1/AKT axis. Front Oncol. 2021;11:754835. doi:10.3389/fonc.2021.754835
   PubMed Web of Science ®Google Scholar
• Tu Z, Wu L, Wang P, et al. N6-methylandenosine-related lncRNAs are potential biomarkers for predicting the overall survival of lower-grade glioma patients. Front Cell Dev Biol. 2020;8:642. doi:10.3389/fcell.2020.00642
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Nijman SM, Kobayashi M, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res. 2009;69:7385–7392. doi:10.1158/0008-5472.CAN-09-1089
   PubMed Web of Science ®Google Scholar
• Li Y, Xia L, Tan K, et al. N(6)-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2. Nat Genet. 2020;52:870–877. doi:10.1038/s41588-020-0677-3
   PubMed Web of Science ®Google Scholar
• Boulias K, Greer EL. Biological roles of adenine methylation in RNA. Nat Rev Genet. 2023;24:143–160. doi:10.1038/s41576-022-00534-0
   PubMed Web of Science ®Google Scholar
• Nachiyappan A, Gupta N, Taneja R. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms. FEBS J. 2022;289:1329–1351. doi:10.1111/febs.16334
   PubMed Web of Science ®Google Scholar
• Padeken J, Methot SP, Gasser SM. Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance. Nat Rev Mol Cell Biol. 2022;23:623–640. doi:10.1038/s41580-022-00483-w
   PubMed Web of Science ®Google Scholar
• Deng S, Zhang J, Su J, et al. RNA m(6)A regulates transcription via DNA demethylation and chromatin accessibility. Nat Genet. 2022;54:1427–1437. doi:10.1038/s41588-022-01173-1
   PubMed Web of Science ®Google Scholar
• You H, Li Q, Kong D, et al. The interaction of canonical Wnt/beta-catenin signaling with protein lysine acetylation. Cell Mol Biol Lett. 2022;27:7. doi:10.1186/s11658-021-00305-5
   PubMed Web of Science ®Google Scholar
• Quandt J, Arnovitz S, Haghi L, et al. Wnt-beta-catenin activation epigenetically reprograms T(reg) cells in inflammatory bowel disease and dysplastic progression. Nat Immunol. 2021;22:471–484. doi:10.1038/s41590-021-00889-2
   PubMed Web of Science ®Google Scholar
• Li J, Li MH, Wang TT, et al. SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/beta-catenin/MYC/HMGCS2 axis. Br J Cancer. 2021;125:865–876. doi:10.1038/s41416-021-01490-y
   PubMed Web of Science ®Google Scholar